Low Grip Strength May Flag Future Osteoporosis Risk
Low grip strength and sarcopenia may signal later osteoporosis risk. Here's what prospective studies show, where the evidence stops, and what to watch.
Plasma Metabolomic Frailty Signatures: What They Can Predict
Plasma metabolomic frailty signatures predicted mortality in UK Biobank. See what this aging biomarker signal shows—and why it is not yet a clinical test.
Biological Aging May Help Explain Rising Early-Onset Cancer
Biological aging may be linked to rising early-onset cancer risk. What a large UK Biobank study found—and why it cannot prove cause or guide treatment.
Circadian Alignment May Shape Metabolic Risk Beyond Sleep
Circadian alignment may affect insulin sensitivity and long-term disease risk beyond sleep duration. What wearable, shift-work, and genetic studies show.
APOE4, Vitamin D, Grip Strength, and Dementia Risk
Can vitamin D status and handgrip strength signal lower dementia risk in APOE4 carriers? A 12-year UK Biobank study offers clues, not prevention proof.
DTI-ALPS and Brain Aging: A Promising MRI Biomarker
Can DTI-ALPS measure glymphatic function and brain aging? A 40,488-person MRI study makes it a serious biomarker candidate, not a proven treatment target.